Nifty
Sensex
:
:
11910.15
40412.57
53.35 (0.45%)
172.69 (0.43%)

Chemicals

Rating :
53/99  (View)

BSE: 530019 | NSE: JUBILANT

526.15
5.90 (1.13%)
11-Dec-2019 | 3:56PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  520.65
  •  531.15
  •  514.05
  •  520.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  93366
  •  491.25
  •  898.85
  •  391.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,370.22
  • 14.05
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 11,840.24
  • 0.86%
  • 1.60

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.68%
  • 3.31%
  • 13.77%
  • FII
  • DII
  • Others
  • 0.32%
  • 2.26%
  • 29.66%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.16
  • 9.35
  • 15.84

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.84
  • 19.91
  • 5.27

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.15
  • -6.37
  • -0.07

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.01
  • 16.87
  • 18.25

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.86
  • 2.37
  • 2.70

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.35
  • 9.40
  • 9.54

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Net Sales
2,265.93
2,269.49
-0.16%
2,181.86
2,078.65
4.97%
2,385.58
2,251.96
5.93%
2,377.10
2,067.76
14.96%
Expenses
1,797.48
1,819.31
-1.20%
1,747.26
1,641.05
6.47%
2,027.61
1,794.09
13.02%
1,883.84
1,650.92
14.11%
EBITDA
468.45
450.18
4.06%
434.60
437.60
-0.69%
357.97
457.87
-21.82%
493.26
416.84
18.33%
EBIDTM
20.67%
19.84%
19.92%
21.05%
15.01%
20.33%
20.75%
20.16%
Other Income
12.26
3.83
220.10%
9.70
9.47
2.43%
-6.58
22.91
-
29.02
3.22
801.24%
Interest
71.64
62.72
14.22%
72.58
50.81
42.85%
61.59
72.48
-15.02%
68.27
77.06
-11.41%
Depreciation
116.84
89.48
30.58%
102.69
88.00
16.69%
95.02
181.74
-47.72%
98.40
81.82
20.26%
PBT
292.23
301.81
-3.17%
269.03
286.37
-6.06%
-39.98
226.56
-
355.61
261.18
36.16%
Tax
42.84
92.04
-53.46%
84.05
86.00
-2.27%
60.67
74.16
-18.19%
88.09
48.34
82.23%
PAT
249.39
209.77
18.89%
184.98
200.37
-7.68%
-100.65
152.40
-
267.52
212.84
25.69%
PATM
11.01%
9.24%
8.48%
9.64%
-4.22%
6.77%
11.25%
10.29%
EPS
15.66
13.51
15.91%
11.61
13.00
-10.69%
-6.23
9.94
-
16.74
13.64
22.73%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
9,210.47
9,110.82
7,517.84
5,861.43
5,749.13
5,826.25
5,803.36
5,165.95
4,303.13
3,445.62
3,791.13
Net Sales Growth
6.26%
21.19%
28.26%
1.95%
-1.32%
0.39%
12.34%
20.05%
24.89%
-9.11%
 
Cost Of Goods Sold
3,376.83
3,521.84
2,862.51
2,002.74
2,116.20
2,663.02
2,438.46
2,062.85
1,618.87
1,339.68
1,471.11
Gross Profit
5,833.64
5,588.98
4,655.33
3,858.69
3,632.94
3,163.23
3,364.90
3,103.10
2,684.26
2,105.95
2,320.02
GP Margin
63.34%
61.34%
61.92%
65.83%
63.19%
54.29%
57.98%
60.07%
62.38%
61.12%
61.20%
Total Expenditure
7,456.19
7,371.81
5,999.45
4,516.14
4,502.19
5,124.71
4,782.37
4,097.81
3,412.94
2,880.76
3,111.07
Power & Fuel Cost
-
466.38
424.91
333.66
366.71
393.04
389.74
356.73
286.89
224.04
220.03
% Of Sales
-
5.12%
5.65%
5.69%
6.38%
6.75%
6.72%
6.91%
6.67%
6.50%
5.80%
Employee Cost
-
1,925.96
1,555.88
1,230.93
1,125.09
1,090.28
1,105.17
962.58
836.36
718.54
735.21
% Of Sales
-
21.14%
20.70%
21.00%
19.57%
18.71%
19.04%
18.63%
19.44%
20.85%
19.39%
Manufacturing Exp.
-
552.26
485.98
428.84
436.46
432.40
405.14
360.48
329.75
284.66
315.90
% Of Sales
-
6.06%
6.46%
7.32%
7.59%
7.42%
6.98%
6.98%
7.66%
8.26%
8.33%
General & Admin Exp.
-
540.75
354.56
280.98
256.23
302.28
264.23
208.35
200.72
195.72
196.68
% Of Sales
-
5.94%
4.72%
4.79%
4.46%
5.19%
4.55%
4.03%
4.66%
5.68%
5.19%
Selling & Distn. Exp.
-
267.70
247.85
185.79
135.54
203.98
160.04
123.28
111.85
90.92
125.97
% Of Sales
-
2.94%
3.30%
3.17%
2.36%
3.50%
2.76%
2.39%
2.60%
2.64%
3.32%
Miscellaneous Exp.
-
96.92
67.76
53.20
65.96
39.72
19.59
23.53
28.50
27.21
125.97
% Of Sales
-
1.06%
0.90%
0.91%
1.15%
0.68%
0.34%
0.46%
0.66%
0.79%
1.22%
EBITDA
1,754.28
1,739.01
1,518.39
1,345.29
1,246.94
701.54
1,020.99
1,068.14
890.19
564.86
680.06
EBITDA Margin
19.05%
19.09%
20.20%
22.95%
21.69%
12.04%
17.59%
20.68%
20.69%
16.39%
17.94%
Other Income
44.40
35.74
40.03
24.86
13.37
42.45
19.06
29.87
31.48
17.24
118.09
Interest
274.08
219.81
284.28
341.11
371.35
367.61
337.11
310.93
238.23
119.99
155.57
Depreciation
412.95
370.90
415.05
291.40
346.74
287.95
281.17
253.79
220.65
180.10
124.68
PBT
876.89
1,184.04
859.08
737.64
542.22
88.43
421.78
533.29
462.79
282.02
517.90
Tax
275.65
326.80
224.66
163.02
155.40
80.48
69.64
152.36
68.41
13.37
95.94
Tax Rate
31.43%
36.16%
26.15%
22.10%
28.66%
199.55%
33.60%
44.66%
59.95%
5.56%
18.52%
PAT
601.24
574.46
642.81
575.66
391.83
-57.76
109.04
152.73
14.56
229.72
421.46
PAT before Minority Interest
595.92
577.01
634.42
574.63
386.82
-40.16
137.64
188.78
45.69
227.23
421.95
Minority Interest
-5.32
-2.55
8.39
1.03
5.01
-17.60
-28.60
-36.05
-31.13
2.49
-0.49
PAT Margin
6.53%
6.31%
8.55%
9.82%
6.82%
-0.99%
1.88%
2.96%
0.34%
6.67%
11.12%
PAT Growth
-22.46%
-10.63%
11.66%
46.92%
778.38%
-152.97%
-28.61%
948.97%
-93.66%
-45.49%
 
Unadjusted EPS
37.78
36.86
41.25
36.93
25.10
-3.63
6.85
9.59
0.91
14.42
28.56

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
4,808.92
4,086.53
3,436.04
2,966.26
2,453.52
2,626.51
2,476.12
2,257.03
2,172.27
2,201.34
Share Capital
15.93
15.58
15.57
15.54
15.93
15.45
15.93
15.93
15.93
15.88
Total Reserves
4,792.94
4,070.78
3,419.98
2,950.72
2,437.59
2,611.07
2,460.19
2,241.10
2,156.34
2,185.46
Non-Current Liabilities
4,420.21
3,417.47
3,826.06
3,347.13
4,036.15
2,184.95
3,004.85
3,224.12
3,048.25
3,365.15
Secured Loans
811.65
729.88
1,581.96
2,620.41
3,316.29
1,716.67
1,708.74
2,839.47
2,435.91
2,160.79
Unsecured Loans
3,431.24
2,317.93
1,923.07
392.79
375.00
0.22
760.06
0.45
400.61
1,011.94
Long Term Provisions
114.35
107.08
80.69
70.31
67.04
219.53
237.96
169.70
39.87
0.00
Current Liabilities
2,089.73
2,004.69
1,684.04
2,464.44
2,129.16
3,894.41
2,778.35
2,212.79
2,269.67
1,220.11
Trade Payables
1,020.13
1,136.16
749.49
612.12
721.19
718.14
647.13
836.98
517.43
688.83
Other Current Liabilities
473.57
505.87
572.70
951.43
793.31
1,731.20
898.00
499.55
465.94
64.70
Short Term Borrowings
499.71
244.85
255.60
748.97
517.17
1,187.83
1,131.39
767.07
883.03
0.00
Short Term Provisions
96.31
117.81
106.24
151.93
97.49
257.25
101.84
109.18
403.28
466.59
Total Liabilities
11,318.96
9,457.17
8,898.75
8,739.70
8,618.83
8,863.81
8,370.86
7,762.89
7,532.00
6,824.52
Net Block
5,648.38
5,400.55
5,106.73
5,104.42
4,911.33
5,098.78
4,967.46
4,460.18
3,991.05
3,818.89
Gross Block
6,905.50
6,288.86
5,672.38
5,390.82
7,362.10
7,330.63
6,870.15
6,084.09
5,163.28
4,845.26
Accumulated Depreciation
1,257.12
888.31
565.66
286.40
2,450.76
2,231.85
1,902.69
1,623.92
1,172.22
1,026.38
Non Current Assets
6,734.16
6,267.41
5,950.63
5,864.37
5,904.29
5,935.78
5,809.80
5,465.57
4,940.25
4,357.21
Capital Work in Progress
901.43
670.97
683.78
611.32
596.60
472.39
436.89
685.55
666.71
505.63
Non Current Investment
115.11
123.52
102.71
85.43
39.50
33.99
25.61
19.20
32.75
32.70
Long Term Loans & Adv.
68.59
71.79
56.32
62.67
327.17
328.42
379.47
299.86
249.18
0.00
Other Non Current Assets
0.66
0.58
1.08
0.53
29.68
2.21
0.37
0.79
0.55
0.00
Current Assets
4,584.80
3,189.76
2,948.12
2,875.32
2,714.54
2,928.03
2,561.06
2,297.32
2,591.75
2,455.22
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
223.71
Inventories
1,417.39
1,391.39
1,220.40
1,203.10
1,235.33
1,341.42
1,116.18
1,020.22
691.28
690.95
Sundry Debtors
1,271.55
1,130.76
1,005.30
950.50
819.27
805.87
708.54
652.69
520.45
518.61
Cash & Bank
1,370.41
248.79
459.63
344.58
394.34
479.53
356.05
266.82
1,045.14
503.67
Other Current Assets
525.44
373.06
225.73
244.07
265.59
301.21
380.29
357.59
334.88
518.27
Short Term Loans & Adv.
39.80
45.75
37.06
133.06
144.56
136.04
182.01
256.70
217.50
498.14
Net Current Assets
2,495.07
1,185.06
1,264.08
410.88
585.38
-966.38
-217.29
84.53
322.08
1,235.11
Total Assets
11,318.96
9,457.17
8,898.75
8,739.69
8,618.83
8,863.81
8,370.86
7,762.89
7,532.00
6,824.51

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
1,121.51
1,303.20
1,268.49
1,098.89
783.26
772.27
969.90
707.17
389.75
709.61
PBT
903.81
859.08
737.64
542.22
40.32
207.28
341.14
114.11
240.59
517.90
Adjustment
861.53
687.81
637.90
737.89
725.84
756.60
752.36
795.44
318.42
189.22
Changes in Working Capital
-300.53
14.15
36.88
-133.16
96.40
-110.70
-4.04
-136.91
-84.14
62.58
Cash after chg. in Working capital
1,464.82
1,561.04
1,412.42
1,146.96
862.57
853.18
1,089.46
772.64
474.88
769.70
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-343.31
-257.84
-143.94
-48.07
-79.31
-80.91
-119.56
-65.47
-85.14
-60.57
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1,011.84
-617.70
-450.39
-312.53
-343.33
-174.42
-499.72
-594.31
-352.15
-279.75
Net Fixed Assets
-305.67
-147.58
-115.33
785.60
1,162.43
-166.96
-286.05
-434.15
-275.33
-128.63
Net Investments
-57.59
3.34
-0.39
57.01
239.81
-27.56
-18.79
-95.66
5.14
-159.67
Others
-648.58
-473.46
-334.67
-1,155.14
-1,745.57
20.10
-194.88
-64.50
-81.96
8.55
Cash from Financing Activity
657.43
-901.13
-685.87
-842.75
-502.69
-414.41
-449.76
-888.82
608.21
-298.02
Net Cash Inflow / Outflow
767.10
-215.63
132.22
-56.38
-62.76
183.44
20.41
-775.95
645.81
131.84
Opening Cash & Equivalents
244.18
456.44
339.27
391.64
473.49
279.65
263.08
1,041.15
498.27
381.66
Closing Cash & Equivalent
1,005.40
244.18
456.44
339.27
391.63
473.49
279.65
263.08
1,041.15
505.34

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
301.93
262.33
220.61
190.90
154.04
170.07
155.46
141.70
136.38
137.88
ROA
5.55%
6.91%
6.52%
4.46%
-0.46%
1.60%
2.34%
0.60%
3.17%
6.21%
ROE
12.97%
16.87%
17.95%
14.27%
-1.58%
5.39%
7.98%
2.06%
10.42%
24.42%
ROCE
13.06%
15.21%
14.44%
12.42%
5.72%
7.92%
10.19%
5.79%
6.29%
12.74%
Fixed Asset Turnover
1.38
1.26
1.09
0.92
0.81
0.84
0.82
0.78
0.70
0.82
Receivable days
48.12
51.58
59.43
54.81
49.56
46.53
47.00
48.71
53.83
48.18
Inventory Days
56.26
63.07
73.64
75.51
78.58
75.51
73.76
71.07
71.61
60.59
Payable days
55.42
56.86
54.84
53.44
52.17
51.42
45.33
38.70
50.95
58.42
Cash Conversion Cycle
48.96
57.79
78.23
76.88
75.98
70.61
75.42
81.08
74.50
50.34
Total Debt/Equity
1.01
0.85
1.18
1.51
1.95
1.67
1.71
1.69
1.81
1.45
Interest Cover
5.11
4.02
3.16
2.46
1.11
1.61
2.10
1.48
3.01
4.33

News Update


  • Jubilant Life Sciences pays penalty of Rs 5 lakh
    25th Nov 2019, 11:07 AM

    SAT had reduced the penalty on Jubilant Life Sciences to Rs 5 lakh, levied by markets regulator SEBI for violating norms pertaining to price-sensitive information

    Read More
  • Jubilant Life Sciences’ arm redeems $100 million notes
    22nd Nov 2019, 09:40 AM

    The company has redeemed principal amount of $100 million on pro-rata basis out of $300 million Notes

    Read More
  • SAT reduces penalty on Jubilant Life Sciences to Rs 5 lakh
    8th Nov 2019, 10:32 AM

    The regulator had imposed a fine of Rs 10 lakh on the firm in January 2018

    Read More
  • Jubilant LifeScience - Quarterly Results
    25th Oct 2019, 15:52 PM

    Read More
  • Jubilant Life Sciences’ arm gets ANDA approval for Clomipramine Hydrochloride Capsules
    23rd Oct 2019, 11:17 AM

    As on June 30, 2019, Jubilant had a total of 96 ANDAs for Oral Solids filed in the US

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.